Co-founder of Synthetic Genomics and investor in early-stage private companies
Juan Enriquez is one of those unique individuals who lives in the future and works on the cutting edge of discovery. He is an active investor in early-stage private companies in the life sciences sector, and is one of the world’s leading authorities on the uses and benefits of genomic research.
Bio-science is beginning to affect the way we live, work, and do business, and Juan Enriquez is an articulate and effective advocate of its promise. Synthetic Genomics, which he co-founded, is a company developing breakthrough genomic-driven solutions for major global issues. They are focused on energy and chemical solutions first but researching a wide range of business solutions in human health (vaccines) and food and water production and the environment. Synthetic Genomics was a partner and major funder of the J. Craig Venter Institute’s recent breakthrough — the creation of the first synthetic bacterial cell.
Moreover, futurist and genomics expert Juan Enriquez is Managing Director at Excel Venture Management and former Director of the Harvard Business School Life Sciences Project. He holds a BA and MBA, with honours, of Harvard University.